David R. Keefer - 04 Jan 2022 Form 4 Insider Report for Virios Therapeutics, Inc. (DWTX)

Role: Director
Signature: /s/ Greg Duncan, Attorney-in-Fact
Issuer symbol: DWTX
Transactions as of: 04 Jan 2022
Net transactions value: +$28,975
Form type: 4
Filing time: 05 Jan 2022, 14:12:06 UTC
Previous filing: 23 Jun 2021
Next filing: 30 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIRI	Common Stock	Purchase	$28,975	+5,000		$5.80^*	5,000	04 Jan 2022	Direct	F1
holding	VIRI	Common Stock						7,808	04 Jan 2022	Ethica Group, LLC	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.75 to $5.80, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F2	The securities are owned directly by Ethica Group, LLC ("Ethica"). The Reporting Person is managing member of Ethica and may be deemed to beneficially own the securities held directly by Ethica.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.75 to $5.80, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

The securities are owned directly by Ethica Group, LLC ("Ethica"). The Reporting Person is managing member of Ethica and may be deemed to beneficially own the securities held directly by Ethica.